Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.

Apex Legends will hold one of its biggest events to date in New Orleans this May, as the ALGS Open will feature 160 Pro ...

The inaugural ALGS Open is set to begin at the Ernest N. Morial Convention Center from May 1-4, 2025, marking what is ...

The ALGS Open will take place in New Orleans, LA from May 1-4, with a massive 160 Apex teams participating in the first ...

Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral ...

Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...

The cartel still expects demand to grow by 1.45 million barrels a day this year and 1.43 million barrels a day the next, ...

After announcing the response, the EU released a 99-page list of possible items that could be subject to tariffs, including ...

H.C. Wainwright lowered the firm’s price target on Aligos Therapeutics (ALGS) to $70 from $75 and keeps a Buy rating on the shares. The firm is ...

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...

Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of -78.53% and 51.62%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock ...